1565 - Nabiximols (Answered)

Steve McCabe
To ask the Secretary of State for Health, if he will direct NICE to conduct a full technology appraisal of the Sativex form of nabiximols to allow the drug to be prescribed on the NHS.

George Freeman

The National Institute for Health and Care Excellence (NICE) published a clinical guideline on multiple sclerosis in 2014 that does not recommend Sativex (nabiximols) as a clinically and cost effective use of National Health Service resources. This is available at:

www.nice.org.uk/guidance/cg186/chapter/1-recommendations

Therefore we have no plans to ask NICE to carry out a technology appraisal of Sativex for the treatment of spasticity in multiple sclerosis.

It is for commissioners to decide whether to fund this treatment for individual patients.